Improved access to CD20 following B cell receptor cross-linking at Burkitt’s lymphoma cell surfaces
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference32 articles.
1. CD20: a regulator of cell-cycle progression of B lymphocytes;Tedder;Immunol. Today,1994
2. Clinical applications of anti-CD20 antibodies;Gopal;J. Lab. Clin. Med,1999
3. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction;Byrd;Blood,2002
4. Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species;Bellosillo;Blood,2001
5. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas;Manches;Blood,2003
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells;The Journal of Immunology;2016-11-02
2. Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy;International Journal of Oncology;2015-09-16
3. Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells;Biochemical and Biophysical Research Communications;2007-04
4. Rituximab but not Other anti-CD20 Antibodies Reverses Multidrug Resistance in 2 B lymphoma Cell Lines, Blocks the Activity of P-glycoprotein (P-gp), and Induces P-gp to Translocate out of Lipid Rafts;Journal of Immunotherapy;2006-09
5. Anti-CD70 antibodies: a potential treatment for EBV+ CD70-expressing lymphomas;Molecular Cancer Therapeutics;2005-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3